|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings (loss) | |||||
| Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Realized and unrealized (gains) losses on financial instruments, net | |||||
| Impairment of goodwill and intangible assets (note 4) | |||||
| Deferred income tax expense (benefit) | |||||
| Other charges (credits), net | |||||
| Changes in operating assets and liabilities | |||||
| Current and other assets | |||||
| Payables and other liabilities | |||||
| Net cash provided (used) by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expended for property and equipment, including capitalized website development | |||||
| Other investing activities, net | |||||
| Net cash provided (used) by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of debt | |||||
| Repayment of debt | |||||
| Shares repurchased by subsidiary (note 9) | |||||
| Payment of withholding taxes on net share settlements of equity awards | |||||
| Other financing activities, net | |||||
| Net cash provided (used) by financing activities | |||||
| Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Cash paid for interest | |||||
| Cash paid (received) for income taxes | |||||
Loading...
